Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential

Adv Exp Med Biol. 2003:524:293-301. doi: 10.1007/0-306-47920-6_35.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy
  • Dipeptidyl Peptidase 4 / metabolism*
  • Disease Models, Animal
  • Gastric Inhibitory Polypeptide / chemistry
  • Gastric Inhibitory Polypeptide / physiology*
  • Gastric Inhibitory Polypeptide / therapeutic use
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / metabolism
  • Peptide Fragments / therapeutic use
  • Protein Structure, Secondary
  • Rats

Substances

  • Blood Glucose
  • Peptide Fragments
  • Gastric Inhibitory Polypeptide
  • Dipeptidyl Peptidase 4